ITF 2004 ITF vs Travis Moffat

This is the unanimous decision of the independent Anti-Doping Tribunal of the International Tennis Federation (“the ITF”) of the ITF Tennis Anti-Doping Programme 2004 (“the Anti-Doping Programme”) to determine a charge brought against Mr Travis Moffat (“the player”) following a positive drug test result in respect of a urine sample provided by the player on 4 February 2004 at the Sydney International wheelchair tennis event in Sydney, Australia.
In a fax dated 19 May 2004, the player admitted the doping offence, which makes a hearing unnecessary. Written representations are filed by the player and the ITF's solicitors.
In his sample the prohibited substance found was a metabolite of cannabis. The player did not request a B-sample analysis, by this he accepted the results of the A-sample.
The player was paralyzed by a car accident, he replaced the medicine he used with cannabis (THC) for control of all spasm and pain and in the process removed a myriad of side effects and instituted an efficacious treatment for his problems. He didn't use the TCH to enhance is sport performance. He didn't apply for a therapeutic use exemption (TUE) because the use of cannabis as a medicine is illegal.
January 1, 2004, cannabinoids became a prohibited substance for the first time. Cannabis and cannabinoids were not prohibited under the predecessors to the Anti-Programme for 2004.
The tribunal declares that the player shall be ineligible for a period of six months starting from the date of this decision from participating in any capacity in any event or activity (other than authorized anti-doping education or rehabilitation programmes) authorized by the ITF or any national or regional entity which is a member of or is recognized by the ITF as the entity governing the sport of tennis in that nation or region. Any computer ranking points or prize money gained in this period will be forfeited.